AbbVie ABBV Peer Comparison

NYSE ABBV
$250.93 +2.15 (+0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT
Peer Comparison

300 Comparable Companies

Industry Pharmaceuticals

AbbVie Inc. (ABBV) is the 2nd largest of 300 Pharmaceuticals companies by market capitalisation, at 453.04 Bn, behind Johnson & Johnson at 663.08 Bn. It trades on a P/E of 71.80, 280% above the peer median of 18.91. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 JNJ Johnson & Johnson primary H-01 Pharmaceuticals and Biotechnology HG-01 663.08 Bn 31.49 6.77 642.33 Bn
2 ABBV AbbVie Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 453.04 Bn 71.80 7.04 446.51 Bn
3 MRK Merck & Co., Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 370.87 Bn 117.16 5.57 363.78 Bn
4 NVS Novartis Ag primary H-01 Pharmaceuticals and Biotechnology HG-01 305.29 Bn 10.77 4.44 298.00 Bn
5 PFE Pfizer Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 162.10 Bn 37.11 2.54 150.70 Bn
6 SNY Sanofi primary H-01 Pharmaceuticals and Biotechnology HG-01 53.95 Bn 11.58 1.01 46.98 Bn
7 RVMD Revolution Medicines, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 45.00 Bn -25.05 — 45.00 Bn
8 INCY Incyte Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 25.47 Bn 15.75 4.38 20.94 Bn
9 UTHR UNITED THERAPEUTICS Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 20.81 Bn 15.85 6.60 18.15 Bn
10 JAZZ Jazz Pharmaceuticals plc primary H-01 Pharmaceuticals and Biotechnology HG-01 16.02 Bn 16.58 3.48 14.40 Bn
11 NBIX Neurocrine Biosciences Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 22.28 4.69 15.42 Bn
12 EXEL Exelixis, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 14.69 Bn 17.20 6.03 13.85 Bn
13 CORT Corcept Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 12.07 Bn 217.01 14.52 11.76 Bn
14 AXSM Axsome Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.81 Bn -69.64 13.92 10.49 Bn
15 GPCR Structure Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.11 Bn -54.84 — 10.11 Bn
16 CYTK Cytokinetics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 10.11 Bn -13.09 149.40 8.94 Bn
17 NUVL Nuvalent, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
18 KYMR Kymera Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.72 Bn -38.47 92.56 9.03 Bn
19 CRNX Crinetics Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
20 ALKS Alkermes plc. primary H-01 Pharmaceuticals and Biotechnology HG-01 7.72 Bn 116.43 4.63 7.07 Bn
21 BLTE Belite Bio, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 7.62 Bn 0.09 — 7.62 Bn
22 TVTX Travere Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 6.15 Bn -140.40 10.40 6.03 Bn
23 LQDA Liquidia Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 6.12 Bn 44.04 13.57 5.83 Bn
24 AMRN Amarin Corp Plc\Uk primary H-01 Pharmaceuticals and Biotechnology HG-01 5.73 Bn -209.27 30.74 5.41 Bn
25 ACAD Acadia Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.82 Bn 12.64 4.24 3.87 Bn
26 EWTX Edgewise Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.64 Bn -23.51 — 4.64 Bn
27 ELVN Enliven Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.35 Bn -46.65 — 4.35 Bn
28 DFTX Definium Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.22 Bn -11.92 — 4.22 Bn
29 INDV Indivior Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.12 Bn 11.71 3.10 3.90 Bn
30 MANE Veradermics, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.11 Bn -46.17 — 4.11 Bn
31 TARS Tarsus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.93 Bn -83.93 6.48 3.48 Bn
32 CPRX CATALYST PHARMACEUTICALS, INC. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
33 OGN Organon & Co. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.62 Bn 17.31 0.59 2.49 Bn
34 NAMS NewAmsterdam Pharma Co N.V. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -12.08 419.65 2.99 Bn
35 TAK Takeda Pharmaceutical Co Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 2.67 Bn 4.61 0.06 -3.12 Bn
36 SUPN Supernus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.53 Bn -29.70 3.21 2.16 Bn
37 MLYS Mineralys Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.49 Bn -6.84 — 2.49 Bn
38 BEIGF BeOne Medicines Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
39 TRVI Trevi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.46 Bn -64.08 — 2.46 Bn
40 HRMY Harmony Biosciences Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.46 Bn 13.72 2.56 1.65 Bn
41 NUVB Nuvation Bio Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.36 Bn -21.96 13.89 2.36 Bn
42 PVLA Palvella Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.26 Bn -42.59 — 1.95 Bn
43 AUPH Aurinia Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 6.66 6.86 1.69 Bn
44 ETON Eton Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.65 Bn 169.20 16.49 1.63 Bn
45 INVA Innoviva, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.55 Bn 7.98 3.01 0.97 Bn
46 XERS Xeris Biopharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -85.88 4.41 1.36 Bn
47 HROW Harrow, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -43.03 5.24 1.36 Bn
48 LBRX Lb Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -24.58 — 1.42 Bn
49 OPK Opko Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -32.69 2.08 0.92 Bn
50 KURA Kura Oncology, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -4.95 15.26 1.18 Bn
51 PCRX Pacira BioSciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.05 Bn 71.04 1.41 0.80 Bn
52 LXRX Lexicon Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -15.59 24.14 0.81 Bn
53 SGP SpyGlass Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -48.72 — 0.97 Bn
54 DSGN Design Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -11.70 — 0.74 Bn
55 OLMA Olema Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -5.50 — 0.94 Bn
56 COLL Collegium Pharmaceutical, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.76 Bn 15.94 0.95 0.62 Bn
57 PHAT Phathom Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.76 Bn -8.10 3.17 0.58 Bn
58 VSTM Verastem, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -7.12 8.48 0.61 Bn
59 ZVRA Zevra Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn 12.59 5.40 0.51 Bn
60 GYRE Gyre Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn -37.38 6.09 0.70 Bn
61 IVEVF Inventiva S.A. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 7.19 132.94 0.69 Bn
62 AQST Aquestive Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -8.53 12.39 0.57 Bn
63 CRMD CorMedix Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 5.25 1.75 0.40 Bn
64 NVCT Nuvectis Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.65 Bn -18.99 — 0.65 Bn
65 MPLT MapLight Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -3.10 — 0.63 Bn
66 EOLS Evolus, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -17.86 1.94 0.57 Bn
67 SPRY ARS Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -2.52 4.78 0.41 Bn
68 OVID Ovid Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -16.03 326.79 0.40 Bn
69 XFOR X4 Pharmaceuticals, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -5.66 32.21 0.32 Bn
70 IKT Inhibikase Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -6.67 — 0.38 Bn
71 VTVT vTv Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -87.02 11.23 0.41 Bn
72 ACHV Achieve Life Sciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.37 Bn — — 0.37 Bn
73 PALI Palisade Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -12.52 725.63 0.24 Bn
74 VNDA Vanda Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -1.19 1.52 0.16 Bn
75 SION Sionna Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.33 — 0.32 Bn
76 EBS Emergent BioSolutions Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.81 0.41 0.18 Bn
77 IMRX Immuneering Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -5.31 — 0.31 Bn
78 FULC Fulcrum Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -3.30 — 0.29 Bn
79 TTRX Turn Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -37.91 — 0.29 Bn
80 CELG-RI Bristol Myers Squibb Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.03 0.01 -10.78 Bn
81 ZNTL Zentalis Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.04 — 0.29 Bn
82 AKBA Akebia Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.82 1.20 0.11 Bn
83 SIGA Siga Technologies Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.24 Bn — — 0.08 Bn
84 TNXP Tonix Pharmaceuticals Holding Corp. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.37 7.58 0.22 Bn
85 CRDL Cardiol Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -7.36 — 0.22 Bn
86 DERM Journey Medical Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -59.11 3.17 0.19 Bn
87 NERV Minerva Neurosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -31.43 — 0.21 Bn
88 ACOG Alpha Cognition Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.55 15.49 0.17 Bn
89 SLGL Sol-Gel Technologies Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.47 107.91 0.15 Bn
90 MCUJF Medicure Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -37.45 8.18 0.19 Bn
91 LENZ LENZ Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.45 8.72 0.19 Bn
92 MENS Jyong Biotech Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -46.69 — 0.18 Bn
93 LONA LeonaBio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.47 — 0.13 Bn
94 BMEA Biomea Fusion, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.60 — 0.15 Bn
95 VANI Vivani Medical, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.77 — 0.11 Bn
96 NTHI Neonc Technologies Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.79 — 0.13 Bn
97 AARD Aardvark Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.68 — 0.04 Bn
98 CPIX Cumberland Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.44 3.25 0.10 Bn
99 CGTX Cognition Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -2.55 — 0.10 Bn
100 VRCA Verrica Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.59 3.00 0.08 Bn
101 RGC Regencell Bioscience Holdings Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
102 PTHS Pelthos Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -0.76 1.66 0.06 Bn
103 TENX Tenax Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.35 — 0.09 Bn
104 MNOV Medicinova Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -6.98 91.85 0.08 Bn
105 PLRX Pliant Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -0.78 — 0.07 Bn
106 PMVP PMV Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.14 — -0.01 Bn
107 BOLD Boundless Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.01 — 0.06 Bn
108 VERU Veru Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 121.51 — 0.04 Bn
109 ANVS Annovis Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.06 — 0.06 Bn
110 GOSS Gossamer Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.34 1.08 0.00 Bn
111 KPTI Karyopharm Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.26 0.35 -0.01 Bn
112 CLNN Clene Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.43 235.39 0.05 Bn
113 IXHL Incannex Healthcare Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.83 — 0.04 Bn
114 APRE Aprea Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.39 — 0.04 Bn
115 SCLX Scilex Holding Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.08 1.20 -0.08 Bn
116 ACTU Actuate Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.70 — 0.04 Bn
117 GRCE Grace Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.82 — 0.03 Bn
118 NSRX Nasus Pharma Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.64 — 0.03 Bn
119 CPHI China Pharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -7.43 8.49 0.03 Bn
120 UG United Guardian Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 14.50 2.93 0.02 Bn
121 CRVO CervoMed Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.86 79.16 0.03 Bn
122 YARW Yarrow Bioscience, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.24 51.63 0.00 Bn
123 TXMD TherapeuticsMD, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -138.26 7.82 0.02 Bn
124 BYSI BeyondSpring Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.02 — 0.03 Bn
125 ATOS Atossa Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
126 AYTU Aytu Biopharma, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.76 0.42 0.00 Bn
127 BFRI Biofrontera Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.42 0.51 0.02 Bn
128 ALLR Allarity Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.87 903.73 0.02 Bn
129 MIRA Mira Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.54 — 0.01 Bn
130 TVRD Tvardi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.68 — 0.02 Bn
131 CTXR Citius Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.33 2.28 0.03 Bn
132 KPRX Kiora Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.43 — 0.02 Bn
133 ANEB Anebulo Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.64 — 0.01 Bn
134 INTI Inhibitor Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.67 — 0.01 Bn
135 CALC CalciMedica, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 -8.79 -0.01 Bn
136 CURX Curanex Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.97 — 0.00 Bn
137 RVPH Reviva Pharmaceuticals Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.78 — 0.01 Bn
138 ACXP Acurx Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.81 — 0.01 Bn
139 PCSA Processa Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.42 — 0.01 Bn
140 TRAW Traws Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 — 0.00 Bn
141 PULM Pulmatrix, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.25 — 0.01 Bn
142 TCRT Alaunos Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.98 1,350.80 0.00 Bn
143 CVKD Cadrenal Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.30 — 0.00 Bn
144 BICX BioCorRx Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.64 6.70 0.00 Bn
145 ADXN Addex Therapeutics Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.05 — 0.00 Bn
146 CASIF CASI Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
147 OGEN Oragenics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.23 — 0.00 Bn
148 CANF Can-Fite BioPharma Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.24 5.93 0.00 Bn
149 UPC Universe Pharmaceuticals INC primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -1,490.23 Bn
150 JAGX Jaguar Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 0.05 -0.01 Bn
151 ENSC Ensysce Biosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
152 MTNB Matinas BioPharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.16 — 0.00 Bn
153 SKVI Skinvisible, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.05 54.04 0.00 Bn
154 SPRC SciSparc Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.05 0.76 0.00 Bn
155 NCEL NewcelX Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 — 0.00 Bn
156 GLMD Galmed Pharmaceuticals Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
157 CDT CDT Equity Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
158 GCAN Trafalgar International, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.77 — 0.00 Bn
159 CINGW Cingulate Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — 0.00 Bn
160 SXTC China SXT Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.03 -0.03 Bn
161 CMND Clearmind Medicine Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — -0.01 Bn
162 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 236.37 Bn 27.00 6.20 222.38 Bn
163 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.38 Bn -64.83 6.15 184.12 Bn
164 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.36 Bn 31.45 10.99 130.51 Bn
165 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 85.09 Bn 19.66 5.48 77.10 Bn
166 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 63.93 Bn 36.92 12.23 58.75 Bn
167 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 58.07 Bn -18.38 26.07 52.94 Bn
168 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.34 Bn 60.81 2.45 38.68 Bn
169 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 35.59 Bn 45.89 7.41 32.28 Bn
170 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 34.36 Bn 54.08 3.19 32.91 Bn
171 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 39.08 3.25 31.34 Bn
172 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 31.10 Bn 15.21 1.46 29.22 Bn
173 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.57 Bn -31.36 24.23 26.41 Bn
174 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 26.24 Bn -14.72 8.48 12.58 Bn
175 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.24 Bn -16.96 2,310.98 25.93 Bn
176 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.39 Bn -47.81 1.32 18.50 Bn
177 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.70 Bn 22.24 2.20 18.30 Bn
178 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 16.77 Bn 18.91 11.83 15.82 Bn
179 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.77 Bn -49.43 12.28 14.93 Bn
180 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.62 Bn -21.18 20.50 13.91 Bn
181 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.44 Bn 40.58 4.11 13.83 Bn
182 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.96 Bn — — 13.27 Bn
183 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 176.35 3.78 12.00 Bn
184 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.57 Bn 31.25 7.55 12.34 Bn
185 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.19 Bn -45.49 18.20 10.58 Bn
186 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.15 Bn 74.93 14.45 11.63 Bn
187 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
188 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.51 Bn 19.74 3.34 9.91 Bn
189 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.46 Bn -66.34 17.06 10.34 Bn
190 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
191 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.99 Bn 789.75 2.73 9.85 Bn
192 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.82 Bn -26.87 — 9.06 Bn
193 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn -45.28 11.01 7.57 Bn
194 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.42 Bn 87.02 33.42 9.42 Bn
195 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.86 Bn -8.36 — 8.86 Bn
196 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.57 Bn 17.97 10.72 7.89 Bn
197 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn -8.55 51.33 8.15 Bn
198 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn -14.99 — 8.10 Bn
199 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn -42.14 — 7.84 Bn
200 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
201 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.07 Bn -33.52 29.47 6.74 Bn
202 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn -734.96 5,007.81 6.97 Bn
203 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.73 Bn -17.90 — 6.73 Bn
204 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.59 Bn -29.38 1,058.74 6.59 Bn
205 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.53 Bn -7.43 10.57 6.10 Bn
206 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.45 Bn -39.59 1.21 6.14 Bn
207 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -16.08 — 5.96 Bn
208 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -33.18 1,163.52 5.66 Bn
209 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn — — 4.09 Bn
210 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn -16.41 — 5.78 Bn
211 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn 15.04 5.72 3.55 Bn
212 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.69 Bn 29.05 19.58 4.33 Bn
213 AMRX Amneal Pharmaceuticals, Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 5.57 Bn 25.85 1.79 5.53 Bn
214 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.06 Bn -17.55 — 5.06 Bn
215 FMCQF Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 4.79 Bn 4.57 0.17 4.09 Bn
216 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.68 Bn -23.96 — 4.68 Bn
217 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.63 Bn — — 4.23 Bn
218 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.16 Bn -13.51 402.01 4.16 Bn
219 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.07 Bn -7.58 — 4.07 Bn
220 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.78 — 4.02 Bn
221 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.98 Bn -18.93 12.25 3.68 Bn
222 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.84 Bn -16.67 16.41 3.01 Bn
223 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -31.20 — 3.80 Bn
224 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -32.98 70.47 2.78 Bn
225 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn -8.13 32.18 3.06 Bn
226 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.72 Bn -521.64 4.64 3.43 Bn
227 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.56 Bn -8.16 987.61 3.56 Bn
228 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.50 Bn -21.21 52.94 3.50 Bn
229 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn -10.05 19,714.47 3.11 Bn
230 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.04 Bn -15.22 — 3.04 Bn
231 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn -11.21 593.06 2.51 Bn
232 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn 109.49 6.47 2.76 Bn
233 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.23 — 2.96 Bn
234 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -15.57 6.55 2.24 Bn
235 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -80.78 — 2.80 Bn
236 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.73 Bn -22.89 553.22 2.73 Bn
237 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn -8.51 73.73 2.27 Bn
238 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.61 Bn -21.89 2.00 2.52 Bn
239 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.60 Bn -6.02 36.49 2.60 Bn
240 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.59 Bn -174.08 10.31 2.48 Bn
241 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -6.44 — 2.59 Bn
242 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -6.59 4.75 2.19 Bn
243 BHC Bausch Health Companies Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 2.45 Bn -2.25 0.23 1.58 Bn
244 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn -20.64 44.92 1.77 Bn
245 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
246 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -17.30 1.20 1.58 Bn
247 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -4.03 — 2.10 Bn
248 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -7.91 44.88 2.34 Bn
249 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.30 Bn -10.51 — 1.93 Bn
250 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn -9.16 — 2.22 Bn
251 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn -15.84 109.75 2.19 Bn
252 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 13.20 4.23 2.03 Bn
253 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.17 0.34 0.66 Bn
254 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn -35.67 11.42 2.05 Bn
255 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -14.21 56.15 1.81 Bn
256 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -4.99 2,082.32 2.08 Bn
257 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -12.36 18.84 1.60 Bn
258 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -4.78 20.06 1.97 Bn
259 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -3.72 35.35 1.39 Bn
260 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -7.59 6.35 1.93 Bn
261 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -9.47 67.43 1.57 Bn
262 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -101.76 4.32 0.98 Bn
263 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -6.99 — 1.32 Bn
264 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -10.09 7.27 1.29 Bn
265 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.80 Bn -4.55 — 1.80 Bn
266 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -14.23 1,370.98 1.78 Bn
267 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -27.67 — 1.39 Bn
268 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -207.39 1,008.79 1.73 Bn
269 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
270 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -12.73 — 1.71 Bn
271 ANIP Ani Pharmaceuticals Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 1.70 Bn 13.96 1.74 1.34 Bn
272 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -6.79 4.07 0.97 Bn
273 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -118.55 16.97 1.68 Bn
274 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -9.11 20.12 1.38 Bn
275 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -68.24 8.28 1.36 Bn
276 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
277 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -8.49 — 1.53 Bn
278 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -11.47 969.66 1.31 Bn
279 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -3.37 2.10 1.22 Bn
280 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn -9.00 — 1.50 Bn
281 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -14.58 72.74 1.45 Bn
282 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -6.70 — 1.42 Bn
283 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn -5.85 165.97 0.88 Bn
284 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 80.09 35.55 1.37 Bn
285 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -1.48 — 1.36 Bn
286 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -8.83 — 1.33 Bn
287 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.32 Bn -27.62 5.09 0.90 Bn
288 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.85 26.37 0.82 Bn
289 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.18 — 0.74 Bn
290 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -7.93 — 1.26 Bn
291 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -4.90 — 1.26 Bn
292 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -28.78 3.20 1.15 Bn
293 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -18.17 — 1.25 Bn
294 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -12.42 51.51 1.24 Bn
295 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn -27.82 — 1.00 Bn
296 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -20.55 — 1.18 Bn
297 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -9.12 41.06 0.55 Bn
298 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn -9.77 — 1.10 Bn
299 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.06 Bn -118.02 — 1.06 Bn
300 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.93 Bn